Vivo Medtech ApS: Financial statements 2025
CVR: 44678675
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Vivo Medtech ApS (CVR 44678675) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 199,640 and a net result of DKK -34,745 compared with DKK -6,178 the year before. That is an increase of 166% compared with the year before. Equity in the 2025 report amounted to DKK -923. The company had 1 employee in the financial year.
- Gross Profit
- DKK 199,640
- Profit/Loss
- DKK -34,745
- Equity
- DKK -923
- Total Assets
- DKK 26,542
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 200 t. | -35 t. | -923 | 1 |
| 2024 | - | 75 t. | -6 t. | 34 t. | 1 |
Official annual report
How creditworthy is Vivo Medtech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of August 20, 2025, Nicolai Pelé Penzien Mamsen is registered as adm. dir. of Vivo Medtech ApS.
As of August 20, 2025, Frederik Penzien Wainer Mamsen has stepped down as adm. dir. of Vivo Medtech ApS.
Vivo Medtech ApS has published its interim report for the period February 28, 2024 – December 31, 2024.
About Vivo Medtech ApS
Vivo Medtech ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 2024. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Nicolai Pelé Penzien Mamsen and Simon Weiss Bonde. The company is owned by Manola ApS, NM Holding 2025 ApS and Simbo Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 199,640 and a net result of DKK -34,745 compared with DKK -6,178 the year before. Equity in the 2025 report amounted to DKK -923.